Neurological Complications of Pregnancy

被引:0
作者
H. Steven Block
机构
[1] SSM Healthcare-Dean Medical Group,
来源
Current Neurology and Neuroscience Reports | 2016年 / 16卷
关键词
Pregnancy; Cerebrovascular disorders; Epilepsy; Neuromuscular disorders;
D O I
暂无
中图分类号
学科分类号
摘要
Physiologic alterations during pregnancy create an environment for the occurrence of disease states that are either unique to pregnancy, occur more frequently in pregnancy, or require special management considerations that may be different from the nonpregnancy state. In the realm of cerebrovascular disease, preeclampsia, eclampsia, reversible cerebral vasoconstriction syndrome, sources of cardiogenic embolization including peripartum cardiomyopathy, cerebral venous thrombosis, pituitary apoplexy, subarachnoid hemorrhage, intracerebral hemorrhage, and special considerations for anticoagulation during pregnancy will be discussed. Management of epilepsy during pregnancy counterbalances maternal freedom from seizures against the potential for major, minor, cognitive, and behavioral fetal deformities. Teratogenic potential of the most common anticonvulsants are described. Considerations for anticonvulsant level monitoring during pregnancy are based upon differences in medication clearance in comparison to the prepregnancy state. The most common neuromuscular disorders of pregnancy are reviewed.
引用
收藏
相关论文
共 211 条
[1]  
Koga K(2003)Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 2348-51
[2]  
Osuga Y(2006)Soluble endoglin and other circulating anti-angiogenic factors in preeclampsia N Engl J Med 355 992-1005
[3]  
Yoshino O(2007)Sequential changes in anti-angiogenic factors in early pregnancy and risk of developing preeclampsia Hypertension 50 137-42
[4]  
Levine RJ(1996)Blood clotting activation during normal pregnancy Thromb Res 84 199-202
[5]  
Lam C(1997)Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis Eur J Obstet Gynecol Reprod Biol 73 31-6
[6]  
Qian C(2013)Task Force on Hypertension in Pregnancy Obstet Gynecol 122 1122-31
[7]  
Rana S(2009)Disseminated intravascular coagulation (DIC) in pregnancy and the peri-partum period Thromb Res 123 S63-4
[8]  
Karumananchi SA(2005)Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ 330 565-72
[9]  
Levine RJ(2005)A sister’s risk: family history as a predictor of preeclampsia Am J Obstet Gynecol 193 965-24
[10]  
Comeglio P(2015)Preeclampsia: syndrome or disease? Curr Hypertens Rep 17 83-76